HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 335 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $573 | +5.9% | 15 | 0.0% | 0.00% | – |
| Q2 2023 | $541 | -54.3% | 15 | -51.6% | 0.00% | – |
| Q1 2023 | $1,184 | -32.9% | 31 | 0.0% | 0.00% | – |
| Q4 2022 | $1,764 | +76.4% | 31 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 31 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 31 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 31 | +19.2% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 26 | -13.3% | 0.00% | – |
| Q3 2021 | $1,000 | -50.0% | 30 | -42.3% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 52 | +23.8% | 0.00% | – |
| Q1 2021 | $2,000 | -33.3% | 42 | -37.3% | 0.00% | -100.0% |
| Q4 2020 | $3,000 | +50.0% | 67 | -2.9% | 0.00% | – |
| Q3 2020 | $2,000 | +100.0% | 69 | +53.3% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 45 | -22.4% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 58 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 58 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | – | 58 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |